Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
### **Patient eligibility and diagnosis** Documentation must confirm that through thorough patient assessment, it is found that they have severe eosinophilic asthma, evidenced by a blood eosinophil count 150 cells/L within six weeks of dosing, and persistent severe asthma uncontrolled despite treatment with high-dosage inhaled corticosteroids plus a second controller
Compounding is defined as the preparation of a medication to meet the unique needs of a patient that cannot be met with an FDA-approved drug
The reconstitution instructions are specific to the batch
Schedule your appointment with us today
US$ 24.62
US$ 27.62
US$ 23.66
US$ 28.67
US$ 23.92
US$ 20.63
